Population Pharmacokinetics for Pediatric Extrapolation of GenSci006: A 3.75-mg Triptorelin Acetate Microsphere Formulation for Central Precocious Puberty

Clinical Pharmacokinetics · Published 2026-04-09 · DOI 10.1007/s40262-026-01634-4

Authors being retrieved — see the publisher record. https://doi.org/10.1007/s40262-026-01634-4

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Population Pharmacokinetics of Bosutinib in Children with Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Based on a Phase I Dose-Finding Trial (ITCC-054/COG AAML1921) and Pediatric Recommended Phase II Dosage Evaluation · Clinical Pharmacokinetics · 2026 · Same journal
• Quantitative Pharmacology Justifying Ribociclib Dose in Early Breast Cancer · Clinical Pharmacokinetics · 2026 · Same journal
• Development and Clinical Application of a Real-World Population Pharmacokinetic Model of Rivaroxaban in Asian Patients with Atrial Fibrillation · Clinical Pharmacokinetics · 2026 · Same journal
• Therapeutic Drug Monitoring of Imatinib in Paediatric Chronic Myeloid Leukaemia: Towards Practical Implementation and Interpretation of Measured Plasma Concentrations · Clinical Pharmacokinetics · 2026 · Same journal
• A Review of Population Pharmacokinetic Models and Dosing Algorithms Assessing the Influence of CYP3A5 Genotype and Other Clinical Covariates on Tacrolimus Pharmacokinetics · Clinical Pharmacokinetics · 2026 · Same journal
• Single Saliva Sample Linezolid Dosing for Multidrug-Resistant Tuberculosis: A Population Pharmacokinetic Modelling of Plasma and Saliva · Clinical Pharmacokinetics · 2026 · Same journal
• Revisited Pharmacokinetic Profiles of Methylprednisolone in Plasma and Urine After Single and Multiple Oral Administrations: Relevance in Sports Drug Testing · Clinical Pharmacokinetics · 2026 · Same journal
• Impacts of Uremic Toxins on the Population Pharmacokinetics of Total Mycophenolic Acid and its Glucuronide Metabolite in Adult Kidney Transplant Recipients · Clinical Pharmacokinetics · 2026 · Same journal
• ALBI Grade is a Determinant of Lenvatinib Pharmacokinetics, Efficacy, and Toxicities in Japanese Patients with Hepatocellular Carcinoma · Clinical Pharmacokinetics · 2026 · Same journal
• Population Pharmacokinetic Modeling of Encorafenib in Healthy Participants and Patients with BRAF V600-Mutant Solid Tumors: A Semi-mechanistic Autoinduction Model · Clinical Pharmacokinetics · 2026 · Same journal